2Hughes LL,Baruzzi MJ,Ribelro RC,et al.Paratesticular rhabdomyosarcoma;Delayed effects of multimodality therapy and implicatlons for current management.Cancer,1994,73:476.
3Weiss SW, Goidblum JR. Rhabdomyosarcoma [ M]//Weiss S W, Goidb|um J R. Enzinger and Weiss's soft tissue. 4thed. St. Louis : C. V. Mosby,2011:783-835.
4Breitfeld PP, Meyer WH. Rhabdmyosarcoma: new windows of op- portunity [ J]. Oncologist,2005,10(7 ) :518-527.
5Walterhouse D, Watson A. Optimal management strategies for rhab- domyosarcoma In children [ J]. Paediatr Drugs,2007,9 (6) :391- 400.
6Ferrari A, Dileo P, Casanova M, et al. Rhabdomyosarcoma in a- dults. A retrospective analysis of 171 patients treated at a single in- stitution [ J]. Cancer,2003,98 (3) :571-580.
